These differences highlight the importance of incorporating 3D culture systems in preclinical evaluations of drug efficacy, and suggest that tumor context and cellular organization may influence FAK inhibitor sensitivity (Bresciani et al. 2019b). The gene discussed is PTK2; the disease is neoplasm.